Care of persons with MS in clinical practice: Management by majority

Affiliations

¹ Departments of Internal Medicine and Community Health Sciences (RAM), University of Manitoba, Winnipeg, Canada; and Department of Neurology (MKR), Ohio State University, Columbus.

Editorial

Ruth Ann Marrie et al. Neurol Clin Pract. 2016 Aug.

. 2016 Aug;6(4):288-290.

doi: 10.1212/CPJ.0000000000000281.

¹ Departments of Internal Medicine and Community Health Sciences (RAM), University of Manitoba, Winnipeg, Canada; and Department of Neurology (MKR), Ohio State University, Columbus.

No abstract available

Comment on

Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.
Tornatore C, Phillips JT, Khan O, Miller AE, Hughes M. Tornatore C, et al. Neurol Clin Pract. 2016 Aug;6(4):329-338. doi: 10.1212/CPJ.0000000000000254. Neurol Clin Pract. 2016. PMID: 27574570 Free PMC article. Review.
Considerations in the development of generic disease therapies for multiple sclerosis.
Hua LH, Cohen JA. Hua LH, et al. Neurol Clin Pract. 2016 Aug;6(4):369-376. doi: 10.1212/CPJ.0000000000000267. Neurol Clin Pract. 2016. PMID: 27574572 Free PMC article. Review.

1. Tornatore C, Phillips JT, Khan O, Miller AE, Hughes M. Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: evolution of treatment practices. Neurol Clin Pract 2016;6:329–338. - PMC - PubMed
1. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–127. - PubMed
1. Frohman EM, Goodin DS, Calabresi PA, et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:602–611. - PubMed
1. Okuda DT, Mowry EM, Cree BAC, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76:686–692. - PMC - PubMed
1. Le Page E, Veillard D, Laplaud DA, et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet 2015;386:974–981. - PubMed